Jacobien R Hilberink
4PUBLICATIONS
36CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (4)
Sort by Publication Date:
|Jun 19, 2023
Age and sex associate with outcome in older AML and high risk MDS patients treated with 10-day decitabine.Jacobien R Hilberink, Isabelle A van Zeventer, Dana A Chitu
|Apr 14, 2023
M2 macrophages drive leukemic transformation by imposing resistance to phagocytosis and improving mitochondrial metabolism.Isabel Weinhäuser, Diego A Pereira-Martins, Luciana Y Almeida
|May 18, 2021
Secondary cytogenetic abnormalities in core-binding factor AML harboring inv(16) vs t(8;21).Se Young Han, Krzysztof Mrózek, Jenna Voutsinas
|Apr 07, 2021
Low relapse risk in poor risk AML after conditioning with 10-day decitabine, fludarabine and 2 Gray TBI prior to allogeneic hematopoietic cell transplantation.Marjan Cruijsen, Jacobien R Hilberink, Walter J F M van der Velden
Pageof 1
Frequent Collaborators
1 joint publications
Marjan Cruijsen
1 joint publications
Elizabeth A Morgan
1 joint publications
Hanne Vestergaard
1 joint publications
Michael Boe Møller
1 joint publications
Ana-Iris Schiefer
1 joint publications
Cecilia Arana Yi
1 joint publications
H Joachim Deeg
1 joint publications
Miguel-Angel Perales
1 joint publications
Mark R Litzow
1 joint publications
Ryotaro Nakamura
